Literature DB >> 29319484

Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation: A comment on Wallis and Detsky guest editorial.

Mike Paulden1, Christopher Mccabe2.   

Abstract

Year:  2017        PMID： 29319484      PMCID： PMC5869043          DOI： 10.5489/cuaj.5119

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  5 in total

1.  Ontario's formulary committee: how recommendations are made.

Authors:  Anne M PausJenssen; Peter A Singer; Allan S Detsky
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Accountability for reasonableness: an update.

Authors:  Norman Daniels; James E Sabin
Journal:  BMJ       Date:  2008-10-09

3.  Pitfalls of prioritizing cost-effectiveness in the assessment of medical innovation.

Authors:  Christopher J D Wallis; Allan S Detsky
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

4.  Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.

Authors:  A Gafni; S Birch
Journal:  CMAJ       Date:  1993-03-15       Impact factor: 8.262

Review 5.  Robotic Surgical System for Radical Prostatectomy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.